Login

Healthcare

00:10:00
Positive Financial Results Signal Growth Potential| David Klein, CEO, Canopy Growth Corp.
00:10:00
Cannasouth emphasizes science-led innovation in medicinal cannabis development | Mark Lucas, CEO, Cannasouth Ltd.
00:10:00
Crafting Success in Healthcare: CEO Insights on Industry Trends and Strategies | A. Hadi Chaudhry, CEO, CareCloud Inc.
00:10:00
Biotech Company CEO Discusses CAM2038 on Stockholm Stock Exchange Listing Day | Fredrik Tiberg, CEO, Camurus AB.
00:10:00
Revolutionizing Healthcare Staffing: Harnessing Technology for Efficiency and Success | Cary Grace - President & Chief Executive Officer of AMN HEALTHCARE SERVICES INC
00:10:00
Jerry Shelton & Mark Sawicki of Cryoport: Keynote at Advanced Therapies Congress 2019 | Jerry Shelton - CEO of Cryoport, Inc.
00:10:00
Cryoport CEO Jerrell Shelton Discusses Stock Rally on CNBC's Power Lunch | Jerry Shelton - CEO of Cryoport, Inc.
00:10:00
CEORoadshow: Jerrell Shelton, President & CEO of Cryoport | Jerry Shelton - CEO of Cryoport, Inc.
00:10:00
Empowering Cancer Patients: Cartherix's Innovative Approach to Solid Cancer Treatment|Professor Alan Trounson,CEO,Cartherics
00:10:00
Inside Cartherics: A Comprehensive 5-Minute Investor Overview|Professor Alan Trounson ,CEO,CARTHERICS
00:10:00
Cartherics is now developing NK cells with dual CARs that provide a grab and punch killing mechanism|Professor Alan Trounson,CEO,Cartherics
00:10:00
Tinkering with Appliances to Transforming Clinical Trials|Ryan Jones,CEO,Florence Healthcare
00:10:00
Matthias points out that while the problem is complex and global, starting with small, tangible actions such as a "green pass" for companies to limit their carbon emissions can make a difference|Matthias Steger,CEO,Endogena Therapeutics
00:10:00
Transitioning from IV infusions to subcutaneous injections can indeed make a significant difference in patient comfort and convenience|Lynn Hartung,President,Qprotyn
00:10:00
At the Canadian Investment Conference to discuss the technology behind Theralase's Laser Treatment Therapy, the users, and their market|Roger White,CEO,Theralase Technologies Inc
00:10:00
The company's efforts to transition two key therapeutics targeting Alzheimer's disease and psychiatric disorders towards full commercialization|Stephan Jackman,CEO,Alzamend Neuro Inc

© 2017 - Townhall + Tv